PharmGKB summary: pazopanib pathway, pharmacokinetics

Pharmacogenet Genomics. 2017 Aug;27(8):307-312. doi: 10.1097/FPC.0000000000000292.
No abstract available

Publication types

  • Research Support, N.I.H., Extramural
  • Review

MeSH terms

  • Antineoplastic Agents / adverse effects
  • Antineoplastic Agents / pharmacology*
  • Clinical Trials as Topic
  • Gene Regulatory Networks
  • Humans
  • Indazoles
  • Neoplasms / drug therapy*
  • Neoplasms / genetics
  • Pharmacogenomic Variants*
  • Pyrimidines / adverse effects
  • Pyrimidines / pharmacology*
  • Sulfonamides / adverse effects
  • Sulfonamides / pharmacology*
  • Treatment Outcome

Substances

  • Antineoplastic Agents
  • Indazoles
  • Pyrimidines
  • Sulfonamides
  • pazopanib